Profile data is unavailable for this security.
About the company
GemPharmatech Co Ltd is a China-based company primarily engaged in the research and development, creation, production, sales and related technical services of experimental animal models. The Company’s main products include knockout and conditional knockout mouse models, immunodeficient mouse models, humanized mouse models, disease mouse models, germ-free mouse models and other products. The Company is also engaged in providing custom model generation, custom breeding, one-stop functional efficacy analysis services, and one-stop services from target concept verification to investigational new drug (IND) submission. The Company conducts its business in the domestic and overseas markets.
- Revenue in CNY (TTM)752.70m
- Net income in CNY121.51m
- Incorporated2017
- Employees1.58k
- LocationGemPharmatech Co LtdNo. 12 Xuefu Road, Jiangbei New AreaNANJING 210032ChinaCHN
- Phone+86 2 558243997
- Fax+86 2 558265927
- Websitehttps://www.gempharmatech.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Qingdao Vland Biotech INC | 1.39bn | 83.57m | 3.89bn | 1.57k | 46.75 | 2.19 | -- | 2.80 | 0.329 | 0.329 | 5.50 | 7.01 | 0.4585 | 3.89 | 3.65 | -- | 3.76 | 4.84 | 6.11 | 6.94 | 44.19 | 45.52 | 8.20 | 9.54 | 0.877 | -- | 0.2648 | 32.35 | 10.16 | 9.30 | -22.39 | -4.23 | -2.71 | -6.89 |
| Hinova Pharmaceuticals Inc | 23.61m | -144.57m | 4.19bn | 173.00 | -- | 3.80 | -- | 177.36 | -1.46 | -1.46 | 0.2384 | 11.12 | 0.0171 | 2.37 | 5.59 | 136,467.70 | -10.45 | -26.09 | -11.68 | -29.74 | 95.50 | -- | -612.36 | -78,863.60 | 6.90 | -- | 0.0883 | -- | -- | -38.67 | 32.18 | -- | 139.77 | -- |
| Bide Pharmatech Co Ltd | 1.27bn | 153.31m | 5.00bn | 738.00 | 31.30 | 2.50 | -- | 3.94 | 1.76 | 1.76 | 14.49 | 22.03 | 0.5167 | 0.8804 | 5.25 | 1,720,520.00 | 6.24 | 7.02 | 7.52 | 8.29 | 43.30 | 42.16 | 12.07 | 13.13 | 2.78 | -- | 0.1055 | 48.73 | 0.9298 | 34.69 | 7.17 | -- | 80.65 | -- |
| Shouyao Holdings Co Ltd | 2.14m | -206.73m | 5.33bn | 178.00 | -- | 8.15 | -- | 2,488.34 | -1.39 | -1.39 | 0.0144 | 4.40 | 0.0025 | 0.0366 | 0.2625 | 12,033.88 | -23.67 | -32.53 | -27.20 | -36.25 | 95.74 | 99.43 | -9,651.03 | -3,370.01 | 6.42 | -- | 0.0044 | -- | -24.61 | -19.34 | -14.21 | -- | 49.71 | -- |
| Hangzhou Alltest Biotech Co Ltd | 881.63m | 294.76m | 5.33bn | 969.00 | 18.06 | 1.37 | -- | 6.05 | 3.72 | 3.72 | 11.12 | 49.21 | 0.2098 | 2.38 | 6.39 | 909,839.10 | 7.02 | 19.18 | 7.57 | 21.66 | 55.00 | 57.79 | 33.47 | 38.82 | 8.34 | -- | 0.0093 | 35.14 | 14.83 | 29.13 | 67.50 | 30.99 | 71.01 | -- |
| Shanghai Aladdin Biochemical Tech Co Ltd | 599.98m | 83.95m | 6.02bn | 652.00 | 72.83 | 5.64 | -- | 10.03 | 0.2485 | 0.2485 | 1.78 | 3.21 | 0.2785 | 0.4218 | 4.55 | 920,216.30 | 5.04 | 7.81 | 6.90 | 8.60 | 62.21 | 60.61 | 18.09 | 24.95 | 1.53 | 9.15 | 0.3541 | 48.33 | 32.44 | 20.55 | 15.07 | 9.17 | 41.61 | -- |
| GemPharmatech Co Ltd | 752.70m | 121.51m | 6.74bn | 1.58k | 54.68 | 3.06 | -- | 8.96 | 0.3007 | 0.3007 | 1.86 | 5.37 | 0.2807 | 4.51 | 1.88 | 476,993.40 | 4.53 | 7.69 | 5.42 | 8.96 | 61.84 | 68.17 | 16.14 | 25.58 | 3.17 | -- | 0.1295 | 21.94 | 10.39 | 28.94 | -30.89 | 25.88 | 20.02 | -- |
| Jiangsu Yahong Meditech Co Ltd | 279.02m | -362.17m | 6.79bn | 391.00 | -- | 3.83 | -- | 24.32 | -0.642 | -0.642 | 0.4933 | 3.10 | 0.125 | 11.16 | 4.19 | 713,603.90 | -16.84 | -14.30 | -19.15 | -15.01 | 72.22 | 73.78 | -134.65 | -703.80 | 4.96 | -- | 0.1545 | -- | 1,365.55 | -- | 4.09 | -- | 50.48 | -- |
| Beijing Sun-Novo Pharma Research Co Ltd | 1.02bn | 133.01m | 7.13bn | 1.36k | 52.38 | 6.13 | -- | 7.00 | 1.21 | 1.21 | 9.23 | 10.38 | 0.4745 | 35.48 | 1.28 | 653,956.40 | 6.04 | 11.39 | 10.49 | 18.82 | 48.60 | 53.31 | 12.72 | 19.66 | 1.78 | 9.97 | 0.3355 | 11.29 | 15.70 | 35.80 | -3.98 | 30.21 | 3.50 | -- |
| Bio-Thera Solutions Ltd | 845.32m | -368.84m | 9.20bn | 1.17k | -- | 19.00 | -- | 10.88 | -0.8908 | -0.8908 | 2.04 | 1.17 | 0.3702 | 0.7722 | 5.96 | -- | -16.15 | -16.38 | -33.76 | -22.22 | 74.99 | 77.05 | -43.63 | -62.11 | 0.4617 | -34.12 | 0.573 | -- | 5.44 | 302.90 | -29.34 | -- | 11.14 | -- |
| Shanghai Medicilon Inc | 1.08bn | -231.86m | 9.34bn | 2.27k | -- | 4.53 | -- | 8.66 | -1.75 | -1.75 | 8.04 | 15.36 | 0.3759 | 8.56 | 1.68 | 459,338.00 | -8.08 | 3.66 | -9.99 | 4.63 | 16.27 | 31.15 | -21.49 | 6.67 | 2.19 | -- | 0.1508 | 40.97 | -24.01 | 18.22 | -896.21 | -- | 2.54 | -- |
Data as of Mar 03 2026. Currency figures normalised to GemPharmatech Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
20.56%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Zhong Ou Asset Management Co., Ltdas of 30 Jun 2025 | 24.77m | 6.04% |
| Tian Hong Asset Management Co., Ltd.as of 30 Jun 2025 | 8.50m | 5.73% |
| Lion Fund Management Co., Ltd.as of 30 Jun 2025 | 6.11m | 4.12% |
| Golden Trust Sinopac Fund Management Co., Ltd.as of 30 Jun 2025 | 2.24m | 1.51% |
| Fullgoal Fund Management Co., Ltd.as of 30 Jun 2025 | 1.96m | 1.32% |
| China Southern Asset Management Co., Ltd.as of 30 Jun 2025 | 1.95m | 0.48% |
| ICBC UBS Asset Management Co. Ltd.as of 30 Jun 2025 | 1.77m | 0.43% |
| HuaAn Fund Management Co., Ltd.as of 30 Jun 2025 | 1.07m | 0.26% |
| Orient Securities Asset Management Co. Ltd.as of 30 Jun 2025 | 837.14k | 0.56% |
| GF Fund Management Co., Ltd.as of 30 Jun 2025 | 482.17k | 0.12% |
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
